Weekly Edge Case – Bonesupport

Most of the time a stock pressing toward new highs gets more expensive, not less. This week, BONESUPPORT is the exception. The orthopaedic medtech's Value score just stepped up from Fairly Priced (3) to Attractively Priced (4) while the shares trade within a whisker of their 52-week high, the kind of divergence Market Edge exists to flag. Each week we take one company the framework surfaces and read it through Quality Rating together with Value and Momentum. Here, the signal is that Value tick higher, landing on a business whose Momentum was already Very Strong (5).

Read more